Skip to content

A Study on the Effect of Test Food on Joint Function -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-

A Study on the Effect of Test Food on Joint Function -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- - A Study on the Effect of Test Food on Joint Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046566
Enrollment
60
Registered
2022-01-07
Start date
2022-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Active food, 12 weeks consumption Placebo food, 12 weeks consumption

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Males and females aged 40 to 74 years-old with discomfort of joints. 2)Subjects whose knee joints are judged to be not diseased by the investigator according to the Kellgren-Lawrence grade (KL grade) in X-ray at screening tests. 3)Subjects whose BMI are less than 30. 4)Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: Subjects (who) 1)have a history of and/or contract rheumatoid arthritis, or are suspected to have rheumatoid arthritis by screening tests. 2)underwent surgery for chronic pain in joints, ligament injury or meniscus injury. 3)with artificial joints, etc. 4)take joint related medicines (such as poultices, liniments, and/or analgesics, etc.) three or more times a week. 5)have a history of and/or contract serious diseases (eg, liver disease, kidney disease, digestive disease, heart disease, respiratory disease, endocrine disease, metabolic disease and/or joint disease). 6)can't stop using drugs and/or supplements affecting joints during the study period. 7)have allergy to ingredients of test foods. 8)are pregnant or planning to become pregnant or breastfeed during the study period. 9)have donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the last three months prior to screening tests. 10)had participated in other clinical studies within the last one month prior to the current study and/or are planning to participate in other clinical studies during the current study. 11)are judged as unsuitable for the current study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
assessment of joint function

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales department

eigyou27@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026